ctDNA-based molecular residual disease and survival in resectable colorectal cancer
#5PRI RANKED
Most Cited Paper
in Cancer Genomics and Diagnostics
18 Months Post-Publication
Class of 2026
“ctDNA-based molecular residual disease and survival in resectable colorectal cancer”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
Circulating tumor DNA · Minimal residual disease · Circulating tumor DNA · CIRCULATE-Japan GALAXY study · Resectable colorectal cancer · stage II-III colon cancer · stage IV CRC · adjuvant chemotherapy · disease-free survival · overall survival · MRD window · ctDNA dynamics · ctDNA dynamics · ctDNA dynamics · transient clearance · spontaneous clearance · post-resection monitoring · Risk stratification · actionable biomarker subsets
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Cancer Genomics and Diagnostics Papers, Class of 2026. https://pri.pepkio.com/top-papers/cancer-genomics-and-diagnostics/2026. Accessed 2026-08-20. Methodology Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459